World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Italy
2026

D-Index & Metrics

Microbiology

D-Index
96
Citations
38455
World Ranking
497
National Ranking
7

Medicine

D-Index
98
Citations
44067
World Ranking
8811
National Ranking
300

Andrea Antinori publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Andrea Antinori sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 678 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Andrea Antinori D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Antinori sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 96 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in Italy Leader Award
  • 2025 - Research.com Microbiology in Italy Leader Award
  • 2023 - Research.com Microbiology in Italy Leader Award
  • 2022 - Research.com Microbiology in Italy Leader Award

Overview

Andrea Antinori is affiliated with the Catholic University of the Sacred Heart in Italy. Their research primarily spans the field of medicine, with a focus on infectious diseases, virology, epidemiology, neurology, and molecular biology.

The scientist's work is notably concentrated on topics such as COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, HIV research and treatment, HIV/AIDS drug development and treatment, HIV/AIDS research and interventions, long-term effects of COVID-19, and poxvirus research and outbreaks.

Recent papers authored or coauthored by Andrea Antinori include:

  • Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022 (2022, New England Journal of Medicine)
  • Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 (2022, Eurosurveillance)
  • ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population (2020, European Journal of Human Genetics)
  • Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) (2020, Cell Death and Differentiation)
  • Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding (2022, The Lancet Infectious Diseases)

Andrea Antinori frequently collaborates with several co-authors, including:

  • Enrico Girardi
  • Valentina Mazzotta
  • Alessandra Vergori
  • Emanuele Nicastri
  • Roberta Gagliardini

The most common venues where their work is published include:

  • International Journal of Infectious Diseases
  • Viruses
  • Journal of Antimicrobial Chemotherapy
  • Journal of Medical Virology
  • Vaccines

Best Publications

  • Updated research nosology for HIV-associated neurocognitive disorders

    A. Antinori;G. Arendt;J. T. Becker;B. J. Brew

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

    A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

  • Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

    Adriana Ammassari;Rita Murri;Patrizio Pezzotti;Maria Paola Trotta

  • Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.

    Adriana Ammassari;Maria Paola Trotta;Rita Murri;Francesco Castelli

  • Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

    Bonaventura Clotet;Judith Feinberg;Jan Van Lunzen;Marie Aude Khuong-Josses

  • Late presentation of HIV infection: a consensus definition

    A Antinori;T Coenen;D Costagiola;N Dedes

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

    Paul E. Sax;Anton Pozniak;M. Luisa Montes;Ellen Koenig

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

    Valerio Tozzi;Pietro Balestra;Rita Bellagamba;Angela Corpolongo

  • Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.

    Adriana Ammassari;Andrea Antinori;Maria Stella Aloisi;Maria Paola Trotta

  • Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

    Fabrizio Starace;Adriana Ammassari;Maria Paola Trotta;Rita Murri

  • Diagnosis of AIDS-related focal brain lesions A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF

    Andrea Antinori;A. Ammassari;A. De Luca;A. Cingolani

  • All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

    Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  • CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

    Cristina Mussini;Patrizia Lorenzini;Alessandro Cozzi-Lepri;Giuseppe Lapadula

  • Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

    Antonella Cingolani;Andrea Antinori;Maria Gabriella Rizzo;Rita Murri

  • Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

    Andrea De Luca;Roberto Bugarini;Alessandro Cozzi Lepri;Massimo Puoti

  • Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.

    Andrea Antinori;Antonella Cingolani;Lucia Alba;Adriana Ammassari

  • Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

    Krishnan Bhaskaran;Cristina Mussini;Andrea Antinori;Ann Sarah Walker

  • One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects

    Monica Airoldi;Mauro Zaccarelli;Luca Bisi;Teresa Bini

Frequent Co-Authors

Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Carlo Federico Perno
Carlo Federico Perno University of Milan
Andrea De Luca
Andrea De Luca University of Siena
Adriana Ammassari
Adriana Ammassari Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Alessandro Cozzi-Lepri
Alessandro Cozzi-Lepri University College London
Francesca Ceccherini-Silberstein
Francesca Ceccherini-Silberstein University of Rome Tor Vergata
Enrico Girardi
Enrico Girardi Austrian Academy of Sciences
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata
Giuseppe Ippolito
Giuseppe Ippolito Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can expand career opportunities in healthcare and science fields. Many institutions offer shortest online medical billing and coding certificate programs, which provide a quick pathway to entering the medical administration sector.

Beyond microbiology, there are numerous online healthcare degrees that allow learners to specialize in areas like public health, nursing, and health informatics. These programs offer flexibility for working professionals seeking to advance their qualifications.

For those interested in advancing into public health, several mph online programs with easy admission requirements offer accessible routes to earn a Master of Public Health degree without stringent entry criteria. This can complement a microbiology background by focusing on disease prevention and health policy.

Career options also include roles such as a child life specialist, where individuals with a Bachelor’s degree can enter a rewarding healthcare profession. Learn more about the child life specialist salary with bachelor degree and what to expect in this growing field.

Best Scientists Citing Andrea Antinori

Trending Scientists

Recently Published Articles